In April 2021, Pfizer and Moderna announced efficacy results at the six month mark from the phase III trials of their respective covid-19 vaccines.12Pfizer CEO Albert […]
Results of the interim analyses performed after 12 months in the first 111 patients enrolled in phase II Cool AMI trial evaluating safety and effectiveness of […]
Writing in the May 14, 2021 issue of The American Journal of Psychiatry , a multi-institution team of scientists led by researchers at University of California […]